Skip to main content
. 2016 Sep 9;39(11):2019–2025. doi: 10.2337/dc16-1094

Table 1.

Comparison of glucose control and insulin delivery during closed-loop and control period over 21 days

Closed loop (n = 12) Control (n = 12) Paired difference* P
Day-and-night glucose control
 Time spent at glucose level (%)
  3.9 to 10.0 mmol/L 66.6 ± 7.9 47.7 ± 14.4 18.8 ± 9.8 <0.001
  >10.0 mmol/L 29.7 ± 9.2 49.1 ± 16.5 −19.3 ± 11.3 <0.001
  >16.7 mmol/L 5.1 (0.8–5.6) 8.0 (1.9–17.4) −3.6 (−11.9 to −0.65) <0.001
  <3.9 mmol/L 4.3 (1.4–5.2) 2.4 (0.3–5.7) 0.4 (−2.2 to 1.3) 0.33
  <2.8 mmol/L 0.3 (0.0–0.5) 0.1 (0.0–0.7) −0.1 (−0.4 to 0.2) 0.49
 AUCday <3.5 mmol/L (mmol/L × min) 11.1 (1.2–17.4) 2.7 (0.2–20.4) 0.0 (−10.5 to 6.8) 0.21
 Mean glucose (mmol/L) 8.7 ± 0.9 10.5 ± 1.8 −1.8 ± 1.3 0.001
 Within day SD of glucose (mmol/L) 3.7 ± 0.7 4.2 ± 0.8 −0.5 ± 0.7 0.013
 CV of glucose within day (%) 40.5 (38.1–47.7) 38.3 (36.7–43.7) 1.2 (−2.6 to 6.7) 0.18
 CV of glucose between days (%) 19.0 (13.8–23.7) 17.4 (14.9–24.0) −0.5 (−3.9 to 6.0) 0.94
Day-and-night insulin delivery
 Total daily insulin (units/day) 53.5 (39.5–72.1) 51.5 (37.6–64.3) 4.5 (1.6–6.5) 0.006
 Total bolus insulin (units/day) 28.3 (16.7–32.6) 29.4 (23.6–37.6) −4.4 (−8.1 to −1.4) 0.009
 Total basal insulin (units/day) 25.8 (23.0–41.2) 19.9 (14.8–26.3) 7.6 (3.8–14.4) 0.001
 SD of basal insulin delivery (units/h) 1.2 (1.0–1.9) 0.3 (0.1–0.3) 1.1 (0.8–1.6) <0.001
 CV of basal insulin delivery 106.7 (97.2–111.1) 23.9 (12.8–35.2) 79.2 (77.1–91.3) <0.001
 Bolus administrations (n/day) 4.9 (4.8–6.3) 6.3 (5.1–7.6) −1.1 (−1.5 to −0.2) 0.015

Data are presented as mean ± SD or as median (interquartile range). P values are adjusted for period effect.

*Closed-loop minus control. A positive value indicates the value was higher on the closed-loop compared with control.

†Primary end point.

‡AUCday indicates glucose area under curve <3.5 mmol/L per day.